Drug intelligence / Profile preview

desfesoterodine

Development stage
Preclinical
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous (investigational)
01

Overview

Desfesoterodine is a small molecule antimuscarinic agent used in the symptomatic treatment of urinary frequency and incontinence. It acts as a competitive antagonist at muscarinic acetylcholine receptors, particularly those in the bladder, leading to relaxation of bladder smooth muscle and reduction of involuntary contractions. Desfesoterodine is the active metabolite of fesoterodine and also a known human metabolite of tolterodine. Its primary indication is for overactive bladder symptoms such as urgency, frequency, and urge incontinence[8][9][2]. The drug has been investigated for use via intravenous administration[3].

Other names
(R)-5-hydroxymethyl tolterodine5-hydroxymethyltolterodine(R)-2-(3-diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol(+)-N,N-diisopropyl-3-(2-hydroxy-5-hydroxymethylphenyl)-3-phenylpropylamineBenzenemethanol, 3-(1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-hydroxy-desfesoterodindesfesoterodinadesfesoterodinum
02

Targets

CHRM2 (M2)CHRM3 (M3)

Beyond the preview

Go deeper on desfesoterodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desfesoterodine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call